Cite
Frison V, Simioni N, Marangoni A, et al. Clinical Impact of 5 Years of Liraglutide Treatment on Cardiovascular Risk Factors in Patients with Type 2 Diabetes Mellitus in a Real-Life Setting in Italy: An Observational Study. Diabetes Ther. 2018;9(6):2201-2208doi: 10.1007/s13300-018-0503-4.
Frison, V., Simioni, N., Marangoni, A., Balzano, S., Vinci, C., Zenari, L., De Moliner, L., Tadiotto, F., D'Ambrosio, M., Confortin, L., Marin, N., Lombardi, S., Costa, S., Prosperini, G., & Lapolla, A. (2018). Clinical Impact of 5 Years of Liraglutide Treatment on Cardiovascular Risk Factors in Patients with Type 2 Diabetes Mellitus in a Real-Life Setting in Italy: An Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders, 9(6), 2201-2208. https://doi.org/10.1007/s13300-018-0503-4
Frison, Vera, et al. "Clinical Impact of 5 Years of Liraglutide Treatment on Cardiovascular Risk Factors in Patients with Type 2 Diabetes Mellitus in a Real-Life Setting in Italy: An Observational Study." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 9,6 (2018): 2201-2208. doi: https://doi.org/10.1007/s13300-018-0503-4
Frison V, Simioni N, Marangoni A, Balzano S, Vinci C, Zenari L, De Moliner L, Tadiotto F, D'Ambrosio M, Confortin L, Marin N, Lombardi S, Costa S, Prosperini G, Lapolla A. Clinical Impact of 5 Years of Liraglutide Treatment on Cardiovascular Risk Factors in Patients with Type 2 Diabetes Mellitus in a Real-Life Setting in Italy: An Observational Study. Diabetes Ther. 2018 Dec;9(6):2201-2208. doi: 10.1007/s13300-018-0503-4. Epub 2018 Sep 20. PMID: 30238228; PMCID: PMC6250628.
Copy
Download .nbib